These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1486921)

  • 41. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
    Strauss HG; Laban C; Lautenschläger C; Buchmann J; Schneider I; Koelbl H
    Eur J Cancer; 2002 Oct; 38(15):1987-91. PubMed ID: 12376202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer.
    Pectasides D; Economides N; Bourazanis J; Pozadzizou P; Gogou L; Koutsiouba P; Athanassiou A
    Am J Clin Oncol; 1994 Aug; 17(4):307-12. PubMed ID: 8048392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix.
    Stenman J; Lintula S; Hotakainen K; Vartiainen J; Lehväslaiho H; Stenman UH
    Int J Cancer; 1997 Feb; 74(1):75-80. PubMed ID: 9036873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SCC antigen in malignant and nonmalignant squamous lesions.
    Torre GC
    Tumour Biol; 1998; 19(6):517-26. PubMed ID: 9817981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.
    van der Sijde R; de Bruijn HW; Krans M; Bouma J; Aalders JG
    Gynecol Oncol; 1989 Nov; 35(2):227-32. PubMed ID: 2807015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SCC tumour marker and its relationship to clinical stage in squamous cervical cancer.
    Henry RJ; Dodd JK; Tyler JP; Houghton CR
    Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):338-40. PubMed ID: 3453675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
    Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    Ye S; Sun X; Kang B; Wu F; Zheng Z; Xiang L; Lesénéchal M; Heskia F; Liang J; Yang H
    BMC Cancer; 2020 Feb; 20(1):138. PubMed ID: 32085736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum levels of squamous cell carcinoma antigen and carcinoembryonic antigen as tumor markers of vulvar cancer.
    Yamawaki T; Takeshima N; Shimizu Y; Teshima H; Hasumi K
    J Obstet Gynaecol Res; 1996 Aug; 22(4):341-6. PubMed ID: 8870416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy.
    Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K
    Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
    Nam JH; Chang KC; Chambers JT; Schwartz PE; Cole LA
    Gynecol Oncol; 1990 Jul; 38(1):66-70. PubMed ID: 2354828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer].
    Joura E; Gitsch G; Kainz C; Fröhlich B; Biegelmayr C; Kölbl H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():115. PubMed ID: 1286308
    [No Abstract]   [Full Text] [Related]  

  • 57. Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.
    Yedema KA; Kenemans P; Wobbes T; van Kamp GJ; de Bruijn HW; Thomas CM; Massuger LF; Schijf CP; Bon GG; Vermorken JB
    Int J Cancer; 1991 Jan; 47(2):170-9. PubMed ID: 1988362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
    Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy.
    Suzuki Y; Nakano T; Ohno T; Abe A; Morita S; Tsujii H
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):332-6. PubMed ID: 10870643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
    Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.